Indonesia’s $9B Chinese Fighter Jet Deal Shocks the World

Indonesia’s $9B Chinese Fighter Jet Deal Shocks the World

  • Indonesia will buy at least 42 Chinese Chengdu J-10C fighters (a ~$9 billion commitment in the 2026 budget), marking the country’s first major arms purchase from Beijing.
  • “They will be flying over Jakarta soon,” said Defense Minister Sjafrie Sjamsoeddin. The purchase is part of Indonesia’s Trisula Nusantara modernization push. Jakarta also ordered 42 French Dassault Rafales ($8.1B) and 48 Turkish KAAN jets as it replaces aging F-16s and Sukhois.
  • Shift to multipolar procurement: Experts note Indonesia’s “bebas-aktif” non-aligned policy means buying the best platforms regardless of origin [1]. Analyst Beni Sukadis warns that the J-10 deal “could be read as a shift in Indonesia’s security orientation amid China’s growing influence” in Southeast Asia. But many analysts emphasize Jakarta’s focus on capability and sovereignty over bloc allegiances [2].
  • Chinese view: PLA and Chinese officials praise the J-10’s performance. State media quotes a Chinese military researcher calling the J-10 “cost-effective” with outstanding radar and missiles, combat-proven in recent conflicts. China’s defense ministry says it is “willing to share the achievements of China’s equipment development with friendly countries” to promote regional stability.
  • Market impact: Western defense stocks held firm. Lockheed Martin (NYSE: LMT) closed around $495 on Oct. 17 [3] and Boeing (NYSE: BA) about $212 [4]. By contrast, Saab AB (Sweden; maker of the Gripen fighter) dropped ~4.4% to 461.9 SEK [5] on Oct. 17, as analysts note competition from Chinese jets. Tech analysis site TS2.tech observes Indonesia had been evaluating Saab’s Gripen, but had already locked in Rafales and eyed U.S. F-15s. The fighter jet market is heating up worldwide, with Pakistan, Iran and others showing interest in China’s J-10.
  • Next steps: The exact contract details and delivery schedule remain under wraps. Indonesian officials say budget approvals are done, but reports suggest the deal might be financed partly by loans. Deliveries could begin in the late 2020s, with pilot training in China by 2026 [6]. Jakarta insists this deal won’t undermine its ties with the U.S. or France – as one analyst notes, Indonesia is now buying Chinese jets and continuing Rafales and Turkish planes, “yet maintains ties with the United States” [7].

Indonesia’s abrupt pivot to Chinese fighters has captured global attention. Defense analysts say it underscores Jakarta’s insistence on strategic autonomy. “Foreign actors can spread disinformation, but at the end of the day, Indonesia buys what it chooses,” writes analyst Muhammad Zulfikar Rakhmat [8]. In practice, Jakarta is “quietly demonstrating that strategic autonomy is possible” – fielding the latest jets from East and West while balancing great-power pressures [9]. For now, Southeast Asian neighbors and global arms makers will be watching closely how this deal unfolds and how it reshapes the region’s airpower balance.

Sources: Official statements and budget documents; reporting from AP and The Diplomat [10]; expert analysis in Asia Times and FlightGlobal [11] [12]; market data from Reuters and Investing.com [13] [14]; industry commentary from TS2.tech.

Indonesia Setujui Pembelian Jet Tempur Canggih J-10C dari China Senilai Rp139 Triliun ✈️🇮🇩

References

1. asiatimes.com, 2. asiatimes.com, 3. www.investing.com, 4. www.investing.com, 5. www.reuters.com, 6. defencesecurityasia.com, 7. asiatimes.com, 8. asiatimes.com, 9. asiatimes.com, 10. thediplomat.com, 11. asiatimes.com, 12. www.flightglobal.com, 13. www.investing.com, 14. www.reuters.com

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Rani Therapeutics (RANI) Stock Surges 150% on $1B+ Chugai Collaboration – Analysts Weigh In
Previous Story

Rani Therapeutics (RANI) Stock Surges 150% on $1B+ Chugai Collaboration – Analysts Weigh In

Sellas Life Sciences (SLS) Stock Rallies on Promising Leukemia Data – Analysts Eye Triple-Digit Upside
Next Story

Sellas Life Sciences (SLS) Stock Rallies on Promising Leukemia Data – Analysts Eye Triple-Digit Upside

Stock Market Today

  • Danaher Valuation in Focus After 8% 1-Month Gain
    October 19, 2025, 2:38 AM EDT. Danaher (DHR) has posted an 8% gain over the last month and about 10% in the past quarter, signaling renewed investor interest in the life sciences space. Yet the stock's 1-year total return remains negative, underscoring a long-term backdrop that still needs improvement. Analysts frame a bullish case around addressable market expansion from rising global healthcare investment, precision medicine, and AI-assisted diagnostics, which could drive margin expansion and higher EBITDA. The latest narrative pegs a fair value near $244.50, suggesting the stock could be undervalued despite a current price around $209. However, elevated valuation multiples (P/E ~43.9x) versus peers and broader Geopolitical/China risks could cap upside. Investors should weigh near-term momentum against the longer-run growth trajectory and potential policy shocks.
  • Matthews International Sells $18 Million Sea Limited Stake; Portfolio Rebalancing Amid Sea Rally
    October 19, 2025, 1:52 AM EDT. On Oct. 16, 2025, Matthews International Capital Management disclosed the sale of 106,055 shares of Sea Limited (SE) in Q3 2025, an estimated $18.17 million trade based on the quarter's average price. The fund held 213,226 Sea Limited shares as of Sept. 30, 2025, valued at $38.11 million at quarter-end, representing 8.87% of 13F AUM and remaining its 2nd-largest holding. At Sept. 30, 2025, its top holdings included PDD Holdings, Sea Limited, Legend Biotech, Trip.com Group, and Kanzhun. Sea's stock traded around $162.65 on Oct. 16, 2025, up 63.7% YoY and ahead of the S&P 500 by about 54 percentage points over the period. Sea operates Garena, Shopee, and SeaMoney across Southeast Asia and beyond. Matthews' sale appears to be a rebalancing move rather than a negative view.
  • Matthews Sells $18M of Sea Limited Shares, Yet Sea Remains Core Position
    October 19, 2025, 1:50 AM EDT. Matthews International Capital Management disclosed in an Oct. 16, 2025 filing that it sold 106,055 shares of Sea Limited (SE) in Q3, valued at about $18.17 million. The trade reduced Matthews' Sea stake to 213,226 shares, worth roughly $38.11 million as of Sept. 30, 2025, and cut Sea to about 8.87% of AUM while keeping SE as the fund's 2nd-largest holding. Price action around the filing showed Sea at $162.65 on Oct. 16, up about 63.7% year over year and ahead of the S&P 500 by roughly 54 percentage points over that period. Matthews previously built a foothold in Sea in early 2024 when shares traded between $50-$70, and the stock has since tripled, leaving Sea a material pillar in the portfolio.
  • Ameriprise Financial (AMP) Still Undervalued as Growth Catalysts Loom Despite Pullback
    October 19, 2025, 12:44 AM EDT. Ameriprise Financial (AMP) has inched higher by about 0.5% in the latest session, though shares are down roughly 3% over the last month and 11.3% year-to-date. Yet long-term holders have seen strong returns: total shareholder return of about 83.9% over 3 years and 199% over 5 years. The stock trades at about 37% below its estimated intrinsic value and roughly 17% under analyst price targets, with a note that the current price sits in front of a fair value estimate of $550.27 (UNDERVALUED). Potential catalysts include expansion of banking products ( CDs, HELOCs, checking ), and stronger adviser recruitment/tech platforms boosting net interest income and wealth management share. Risks include volatility and asset outflows. Investors should review the underlying assumptions shaping the upside.
  • JMIC Disposes $7.5M of Adobe in Q3 2025: Implications for ADBE
    October 19, 2025, 12:14 AM EDT. Joel R Mogy Investment Counsel disclosed a Q3 2025 sale of 20,929 Adobe shares, roughly $7.51 million, reducing its ADBE stake to 50,664 shares and bringing the position to about 0.98% of AUM ($1.83B) as of Sept. 30, 2025. The trim follows two prior quarters of selling and leaves JMIC with a smaller, still sizable stake in a stock down about 34.9% year over year and ~52% off its all-time high. Adobe remains among the fund's top holdings, but its weight has declined from a two-year peak of 2.5%. As AI-related headwinds and competition reshape the software landscape, investors will weigh whether the stock's long-term subscription model can sustain growth amid a broad market pullback for tech.
Go toTop